185 related articles for article (PubMed ID: 33260593)
1. Mycophenolate Improves Brain-Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats.
Robles-Vera I; de la Visitación N; Sánchez M; Gómez-Guzmán M; Jiménez R; Moleón J; González-Correa C; Romero M; Yang T; Raizada MK; Toral M; Duarte J
Antioxidants (Basel); 2020 Nov; 9(12):. PubMed ID: 33260593
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats.
Robles-Vera I; de la Visitación N; Toral M; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
Biomed Pharmacother; 2021 Mar; 135():111189. PubMed ID: 33388596
[TBL] [Abstract][Full Text] [Related]
3. Changes in Gut Microbiota Induced by Doxycycline Influence in Vascular Function and Development of Hypertension in DOCA-Salt Rats.
Robles-Vera I; de la Visitación N; Toral M; Sánchez M; Romero M; Gómez-Guzmán M; Vargas F; Duarte J; Jiménez R
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578849
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats.
González-Correa C; Moleón J; Miñano S; Robles-Vera I; Toral M; Martín-Morales N; O'Valle F; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
Biomed Pharmacother; 2023 Feb; 158():114149. PubMed ID: 36566524
[TBL] [Abstract][Full Text] [Related]
5. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension.
Robles-Vera I; de la Visitación N; Toral M; Sánchez M; Romero M; Gómez-Guzmán M; Yang T; Izquierdo-García JL; Guerra-Hernández E; Ruiz-Cabello J; Raizada MK; Pérez-Vizcaíno F; Jiménez R; Duarte J
FASEB J; 2020 Oct; 34(10):13626-13640. PubMed ID: 32780919
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats.
Boesen EI; Williams DL; Pollock JS; Pollock DM
Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1016-22. PubMed ID: 20626757
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone.
Moes AD; Severs D; Verdonk K; van der Lubbe N; Zietse R; Danser AHJ; Hoorn EJ
Front Physiol; 2018; 9():578. PubMed ID: 29867591
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive effect of captopril on deoxycorticosterone acetate-salt-induced hypertensive rat is associated with gut microbiota alteration.
Wu H; Lam TYC; Shum TF; Tsai TY; Chiou J
Hypertens Res; 2022 Feb; 45(2):270-282. PubMed ID: 34857899
[TBL] [Abstract][Full Text] [Related]
9. DOCA-salt hypertension and the role of the OVLT-sympathetic-gut microbiome axis.
Pestana-Oliveira N; Nahey DB; Hartson R; Weber B; Johnson TJ; Collister JP
Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):490-497. PubMed ID: 33462863
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
11. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
Wenceslau CF; Rossoni LV
J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
[TBL] [Abstract][Full Text] [Related]
12. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
13. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
[TBL] [Abstract][Full Text] [Related]
14. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs.
González-Correa C; Moleón J; Miñano S; Robles-Vera I; Toral M; Barranco AM; Martín-Morales N; O'Valle F; Guerra-Hernández E; Sánchez M; Gómez-Guzmán M; Jiménez R; Romero M; Duarte J
Br J Pharmacol; 2024 May; ():. PubMed ID: 38770714
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
[TBL] [Abstract][Full Text] [Related]
16. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats.
Nakano D; Itoh C; Ishii F; Kawanishi H; Takaoka M; Kiso Y; Tsuruoka N; Tanaka T; Matsumura Y
Biol Pharm Bull; 2003 Dec; 26(12):1701-5. PubMed ID: 14646174
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
Sharifi AM; Schiffrin EL
J Hypertens; 1997 Dec; 15(12 Pt 1):1441-8. PubMed ID: 9431850
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
[TBL] [Abstract][Full Text] [Related]
19. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
20. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
